The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemes...

por Hadji, Peyman, Stoetzer, Oliver, Decker, Thomas, Kurbacher, Christian M., Marmé, Frederik, Schneeweiss, Andreas, Mundhenke, Christoph, Distelrath, Andrea, Fasching, Peter A., Lux, Michael P., Lüftner, Diana, Janni, Wolfgang, Muth, Mathias, Kreuzeder, Julia, Quiering, Claudia, Grischke, Eva-Marie, Tesch, Hans
Publicado en J Bone Oncol (2018)

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or meta...

por Tesch, Hans, Stoetzer, Oliver, Decker, Thomas, Kurbacher, Christian M., Marmé, Frederik, Schneeweiss, Andreas, Mundhenke, Christoph, Distelrath, Andrea, Fasching, Peter A., Lux, Michael P., Lüftner, Diana, Hadji, Peyman, Janni, Wolfgang, Muth, Mathias, Kreuzeder, Julia, Quiering, Claudia, Taran, Florin‐Andrei
Publicado en Int J Cancer (2018)

Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis

por Schnittger, Susanne, Bacher, Ulrike, Haferlach, Claudia, Beelen, Dietrich, Bojko, Peter, Bürkle, Dieter, Dengler, Robert, Distelrath, Andrea, Eckart, Michael, Eckert, Robert, Fries, Stefan, Knoblich, Jan, Köchling, Georg, Laubenstein, Hans-Peter, Petrides, Petro, Planker, Manfred, Pihusch, Rudolf, Weide, Rudolf, Kern, Wolfgang, Haferlach, Torsten
Publicado 2009